TNYA
Tenaya Therapeutics, Inc.
+0.01 (+1.52%)0.67USD636K成交股數150M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.1M | 225K | – | 0.00 | 0.00 | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 16.6M | 14.8M | 15.4M | 17.4M | 21.1M | 18.7M | 20.4M | 22.6M | 25.1M | 23.1M | 26.5M | 25.6M |
| 銷售管理費用 | 5.4M | 5.4M | 5.6M | 6.7M | 6.5M | 6.0M | 6.4M | 8.2M | 8.7M | 7.8M | 8.6M | 8.1M |
| 營業利益 | −44.1M+60% | −20.1M-19% | −20.9M-22% | −24.1M-22% | −27.5M-18% | −24.7M-20% | −26.7M-24% | −30.8M-9% | −33.8M | −30.9M | −35.1M | −33.7M |
| 營業利益率 | -3,971.9% | -8,917.8% | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −43.4M+62% | −19.3M-19% | −20.3M-21% | −23.3M-21% | −26.9M-17% | −23.8M-18% | −25.6M-23% | −29.4M-7% | −32.2M | −29.1M | −33.3M | −31.7M |
| 淨利率 | -3,909.3% | -8,565.3% | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.20-17% | -0.09-67% | -0.12-60% | -0.14-59% | -0.24-40% | -0.27-31% | -0.30-33% | -0.34-21% | -0.40 | -0.39 | -0.45 | -0.43 |
| 稀釋股數 | 218M | 217M | 163M | 163M | 110M | 84.8M | 86.2M | 85.7M | 81.0M | 73.9M | 73.4M | 73.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 78.1M | 80.9M | 56.3M | 62.7M | 53.8M | 4.3M | 8.2M | 58.1M | 59.3M | 82.2M | 75.6M | 72.5M |
| 應收帳款 | 371K | 10.6M | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 93.5M | 135M | 105M | 122M | 144M | 120M | 141M | 163M | 185M | 193M | 221M | 245M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 24.1M | 28.9M | 22.1M | 22.3M | 24.6M | 27.1M | 28.0M | 29.2M | 26.7M | 28.5M | 30.8M | 29.9M |
| 股東權益 | 69.4M | 106M | 82.9M | 99.8M | 119M | 92.9M | 113M | 134M | 158M | 165M | 190M | 215M |
| 負債比 | 25.8% | 21.4% | 21.1% | 18.3% | 17.1% | 22.6% | 19.9% | 17.9% | 14.5% | 14.7% | 14.0% | 12.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −19.2M | – | – | −23.1M-19% | – | – | – | −28.7M | – | – | −30.3M |
| 資本支出 | – | 11K | – | – | 383K | – | – | – | 564K | – | – | 629K |
| 自由現金流 | – | −19.2M | – | – | −23.5M-20% | – | – | – | −29.2M | – | – | −30.9M |
| 折舊攤銷 | 1.7M | 1.8M | 1.9M | 2.1M | 2.7M | 2.1M | 2.1M | 2.1M | 2.2M | 2.2M | 2.2M | 2.1M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -8,553.3% | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −90.6M | –% | -0.59 | −68.9M |
| FY2024 | – | – | −111M | –% | -1.31 | −91.5M |
| FY2023 | – | – | −124M | –% | -1.68 | −103M |
| FY2022 | – | – | −124M | –% | -2.76 | −125M |
| FY2021 | – | – | −72.7M | –% | -4.10 | −85.9M |
| FY2020 | – | – | −38.4M | –% | -39.50 | −45.2M |